A high-throughput functional complementation assay for classification of BRCA1 missense variants.

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Mutations in BRCA1 and BRCA2 genes are primary causes of hereditary breast and ovarian cancers.
• Sequence analysis identifies numerous BRCA1 variants of uncertain significance (VUS), complicating clinical genetic assessments.
• Existing functional assays for BRCA1 VUS lack high-throughput capabilities for full-length protein analysis.

Purpose of the Study:

• To develop and validate a high-throughput functional assay for classifying BRCA1 variants of uncertain significance (VUS).
• To assess the functional impact of 74 unclassified BRCA1 missense mutants, particularly those in the RING and BRCT domains.

Main Methods:

• A novel cDNA-based functional assay was developed.
• The assay utilizes BRCA1-deficient mouse embryonic stem cells for complementation studies.
• The assay measures the ability of BRCA1 VUS to functionally complement the deficient cells.

Main Results:

• A fast and reliable high-throughput assay for BRCA1 VUS classification was successfully established.
• The assay was validated for its ability to functionally assess BRCA1 variants.
• Seventy-four unclassified BRCA1 missense mutants were analyzed using the developed assay.

Conclusions:

• The developed high-throughput assay provides a reliable method for functional classification of BRCA1 VUS.
• This assay addresses a critical need for clinical geneticists managing patients with hereditary breast and ovarian cancer.
• The assay facilitates improved genetic risk assessment for individuals with uncertain BRCA1 variants.